Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ASA Pharma is a Mexican pharmaceutical company that specializes in the development, manufacturing, and commercialization of high-quality therapeutic products. The company maintains a strong presence in the Latin American market, particularly in therapeutic areas such as gastroenterology, pain management, and respiratory health. Its flagship product line, Libertrim (trimebutine), is widely recognized for treating irritable bowel syndrome and other functional digestive disorders. ASA Pharma operates as part of the Siegfried Rhein group, leveraging extensive regional distribution networks and manufacturing capabilities. The company's portfolio includes both branded medications and generic formulations designed to improve patient access to essential treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ASA Pharma.